02268

59.7005.61%
ZC

Zhisheng Chen

CEO & Executive Director

Dr. Zhisheng Chen, also known as Chris, Ph.D. has been the Chief Executive Officer & Executive Director at WuXi Biologics (Cayman) Inc. since January 01, 2016 and since February 27, 2014 respectively. Dr. Chen is primarily responsible for the overall management of the business of WuXi Biologics (Cayman) Inc. From June 2011 to January 2016, he served as a senior vice president of WXAT Shanghai. He serves as Non-Executive Chairman of WuXi XDC Cayman Inc. since May 2021 and serves as its Director since December 2020. He was primarily engaged in the contract development and manufacturing of bio-pharmaceuticals and small molecules. He was responsible for the management of biologics development and manufacturing. From August 2008 to June 2011, he served as the chief operating officer of Shanghai Celgen Bio-Pharmaceutical Co., Ltd. He was primarily engaged in biologics development, commercial manufacturing and marketing and was responsible for the development, manufacturing and quality control of biologics. From November 2005 to August 2008, he served as a director and senior engineering consultant of Eli Lilly. He was primarily engaged in discovering and manufacturing of medicines and was responsible for running a clinical manufacturing facility and providing technical guidance to biologics development and manufacturing. From June 2000 to November 2005, he served as a process engineer and manager of Merck & Co. Inc. He was primarily engaged in developing and sales of pharmaceuticals and was responsible for providing technical support and trouble-shooting manufacturing issues of biologics and recombinant vaccines. Dr. Chen obtained a bachelor’s degree in chemical engineering from Tsinghua University in June 1994 and a Ph.D. degree in chemical engineering from University of Delaware in June 2000.

Positions